论文部分内容阅读
目的:分析中医优势病种的卫生经济学特点,为进一步深入卫生经济学评价研究奠定基础。方法:随机抽取6家医院病案首页资料,选取中医治疗共识性较好的8个病种,以住院天数进行匹配,以保持组间均衡性,以中药费用是否大于0作为分组依据,分为中医组和西医组,比较两组的平均住院费用、治愈好转率和成效比。结果:8个病种中医治疗组的平均住院费用为10261.85元,治愈好转率为84.11%,成效比为122.00元/%,优于西医治疗组的平均住院费用14274.22元,治愈好转率为77.85%,成效比为183.35元/%。结论:对于某些特定病种,在组间可比的情况下,相对于西医治疗,中医治疗成本低,效果好,成效比占优,具有卫生经济学上的优势。
Objective: To analyze the characteristics of health economics of the dominant disease in TCM and lay the foundation for the further study on the evaluation of health economics. Methods: Six hospitals were randomly selected from the medical records, 8 Chinese patients with better consensus treatment were selected and matched with hospitalization days to keep the balance among groups. Based on whether TCM costs were greater than 0, the study was divided into TCM Group and Western medicine group, comparing the average hospitalization cost, cure improvement rate and effect ratio of the two groups. Results: The average cost of hospitalization for 8 kinds of Chinese medicine treatment group was 10261.85 yuan, the cure improvement rate was 84.11%, the effective ratio was 122.00 yuan /%, which was better than the average hospitalization cost of 14274.22 yuan in western medicine treatment group, the healing improvement rate was 77.85% , The result is 183.35 yuan /%. CONCLUSIONS: For certain specific diseases, compared with Western medicine treatment, the cost of Chinese medicine treatment is low, the effect is good, the effective ratio is dominant, and the health economics is superior to the comparable case.